ETC-1922159
D3-002
Phase 1 small_molecule active
Quick answer
ETC-1922159 for Solid Tumors is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active